233 related articles for article (PubMed ID: 19033566)
21. Adjuvant therapy following resection for pancreatic adenocarcinoma.
Brennan MF
Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934
[TBL] [Abstract][Full Text] [Related]
22. Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer.
Sohal DP; Metz JM; Sun W; Giantonio BJ; Plastaras JP; Ginsberg G; Kochman ML; Teitelbaum UR; Harlacker K; Heitjan DF; Feldman MD; Drebin JA; O'Dwyer PJ
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1485-91. PubMed ID: 23532207
[TBL] [Abstract][Full Text] [Related]
23. Chemoradiation protocols offer only incremental gains for pancreatic cancer patients.
Bankhead C
J Natl Cancer Inst; 2002 Nov; 94(22):1670-2. PubMed ID: 12441320
[No Abstract] [Full Text] [Related]
24. Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment.
Hudson E; Hurt C; Mort D; Brewster AE; Iqbal N; Joseph G; Crosby TD; Mukherjee S
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):27-35. PubMed ID: 19896352
[TBL] [Abstract][Full Text] [Related]
25. Treatment of early-stage pancreatic cancer.
Castellanos EH; Cardin DB; Berlin JD
Oncology (Williston Park); 2011 Feb; 25(2):182-9. PubMed ID: 21456390
[TBL] [Abstract][Full Text] [Related]
26. Emerging drugs in pancreatic cancer.
Ducreux M; Boige V; Malka D
Expert Opin Emerg Drugs; 2004 May; 9(1):73-89. PubMed ID: 15155137
[TBL] [Abstract][Full Text] [Related]
27. The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX.
Fogelman DR; Chen J; Chabot JA; Allendorf JD; Schrope BA; Ennis RD; Schreibman SM; Fine RL
Surg Oncol Clin N Am; 2004 Oct; 13(4):711-35, x. PubMed ID: 15350944
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakagawa N; Ohge H; Sueda T
Am J Surg; 2008 Jun; 195(6):757-62. PubMed ID: 18367131
[TBL] [Abstract][Full Text] [Related]
29. Role of adjuvant therapy in the management of pancreatic cancer.
Laheru D; Yeo CJ
Adv Surg; 2005; 39():223-44. PubMed ID: 16250554
[No Abstract] [Full Text] [Related]
30. [Long term survival after pancreatic resection for pancreatic adenocarcinoma].
Wirtz M; Friess H
Z Gastroenterol; 2002 Sep; 40(9):849-52. PubMed ID: 12215954
[No Abstract] [Full Text] [Related]
31. [Adjuvant treatment of pancreatic cancer].
Oettle H
Zentralbl Chir; 2003 May; 128(5):411-8. PubMed ID: 12813641
[TBL] [Abstract][Full Text] [Related]
32. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial.
Regine WF; Winter KA; Abrams RA; Safran H; Hoffman JP; Konski A; Benson AB; Macdonald JS; Kudrimoti MR; Fromm ML; Haddock MG; Schaefer P; Willett CG; Rich TA
JAMA; 2008 Mar; 299(9):1019-26. PubMed ID: 18319412
[TBL] [Abstract][Full Text] [Related]
33. Developments in the systemic therapy of pancreatic cancer.
el-Rayes BF; Shields AF; Vaitkevicius V; Philip PA
Cancer Invest; 2003; 21(1):73-86. PubMed ID: 12643012
[TBL] [Abstract][Full Text] [Related]
34. [Concomitant chemoradiotherapy and preoperative radiotherapy in exocrine pancreatic adenocarcinoma].
Mornex F; Gérard JP; Chauffert B; Brun M
Ann Chir; 2000 Feb; 125(2):111-7. PubMed ID: 10998795
[TBL] [Abstract][Full Text] [Related]
35. Chemoradiation for localized pancreatic cancer: another perspective.
Evans DB; Abbruzzese JL
Ann Surg Oncol; 1999; 6(1):4-7. PubMed ID: 10030405
[No Abstract] [Full Text] [Related]
36. Adjuvant therapy for surgically resected pancreatic adenocarcinoma.
Abbruzzese JL
JAMA; 2008 Mar; 299(9):1066-7. PubMed ID: 18319419
[No Abstract] [Full Text] [Related]
37. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
Neoptolemos JP; Stocken DD; Bassi C; Ghaneh P; Cunningham D; Goldstein D; Padbury R; Moore MJ; Gallinger S; Mariette C; Wente MN; Izbicki JR; Friess H; Lerch MM; Dervenis C; Oláh A; Butturini G; Doi R; Lind PA; Smith D; Valle JW; Palmer DH; Buckels JA; Thompson J; McKay CJ; Rawcliffe CL; Büchler MW;
JAMA; 2010 Sep; 304(10):1073-81. PubMed ID: 20823433
[TBL] [Abstract][Full Text] [Related]
38. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
39. Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents.
Pisters PW; Hudec WA; Lee JE; Raijman I; Lahoti S; Janjan NA; Rich TA; Crane CH; Lenzi R; Wolff RA; Abbruzzese JL; Evans DB
J Clin Oncol; 2000 Feb; 18(4):860-7. PubMed ID: 10673529
[TBL] [Abstract][Full Text] [Related]
40. [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].
Lluís F
Gastroenterol Hepatol; 2009 Feb; 32(2):120-1. PubMed ID: 19231687
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]